Clinical activity of CC‐90011, an oral, potent, and reversible LSD1 inhibitor, in advanced malignancies
Article in Cancer (June 2022)
The most recent citing publications are shown below. View all 4 publications that cite this research output on Dimensions.
Article in Cancer (June 2022)
Article in Experimental and Therapeutic Medicine (December 2021)
Article in Molecules (December 2021)